Public authorities

Europe Can Forecast Vibrio Risk. It Still Has To Act.

Cardiology has too many dashboards. The danger is forgetting the patient

GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up

Pregnancy complications demand long-term cardiovascular care

MENA’s cardiometabolic crisis is a stability issue

Mpox Reached Guinea-Bissau. Stigma Must Not Win.

The Most Preventable Cause of Vision Loss May Still Be Smoking

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Chemo Shortages Are Back. So Is Rationing.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
